US Stock MarketDetailed Quotes

Vertex Pharmaceuticals (VRTX)

Watchlist
  • 436.580
  • -0.370-0.08%
Close May 18 16:00 ET
  • 434.700
  • -1.880-0.43%
Pre 05:36 ET
110.81BMarket Cap25.91P/E (TTM)

Vertex Pharmaceuticals (VRTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
74.39%1.43B
837.19%3.63B
-14.81%498M
-9.37%1.24B
128.59%1.07B
-37.33%818.9M
-113.93%-492.6M
149.19%584.6M
7.99%1.37B
-430.89%-3.75B
Net income from continuing operations
59.59%1.03B
838.09%3.95B
30.46%1.19B
3.59%1.08B
128.74%1.03B
-41.22%646.3M
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
Operating gains losses
----
----
----
-75.93%2.6M
-142.52%-5.4M
-44.44%15M
9,516.67%57.7M
1,700.00%7.2M
74.19%10.8M
3,075.00%12.7M
Depreciation and amortization
15.50%55.9M
1.25%209.8M
19.78%55.7M
1.50%54M
-4.26%51.7M
-9.53%48.4M
14.29%207.2M
-21.19%46.5M
26.37%53.2M
30.43%54M
Deferred tax
65.92%-65.3M
-46.44%-510.8M
-40.89%30.5M
-91.32%-235.9M
4.21%-113.8M
-21.04%-191.6M
34.99%-348.8M
139.39%51.6M
-6.75%-123.3M
32.73%-118.8M
Other non cash items
-112.76%-5M
12,500.00%113.4M
40.85%23.1M
-116.11%-6.7M
379.23%57.8M
207.69%39.2M
102.11%900K
151.74%16.4M
313.33%41.6M
-84.82%-20.7M
Change In working capital
191.14%244.7M
-132.93%-1.2B
-69.19%-947.8M
-5.02%149.6M
45.15%-132.4M
-307.66%-268.5M
-93.75%-514.8M
33.22%-560.2M
-16.62%157.5M
-198.37%-241.4M
-Change in receivables
123.47%39.8M
-249.75%-347.3M
-244.06%-99.4M
-15.64%-59.9M
-113.62%-18.4M
32.59%-169.6M
-18.07%-99.3M
348.05%69M
-749.18%-51.8M
4,758.62%135.1M
-Change in inventory
41.53%-97.7M
-1.33%-524.2M
47.53%-77.4M
28.16%-131.1M
-38.62%-148.6M
-108.61%-167.1M
-60.20%-517.3M
-110.71%-147.5M
-87.18%-182.5M
-47.25%-107.2M
-Change in prepaid assets
717.08%173.4M
-97.70%-396M
-52.25%-250.6M
-294.76%-40.9M
50.99%-76.4M
-128.33%-28.1M
63.29%-200.3M
63.53%-164.6M
117.36%21M
-695.41%-155.9M
-Change in payables and accrued expense
42.80%106.1M
-130.53%-80.1M
-100.90%-626.2M
25.73%297.6M
21.65%174.2M
-61.74%74.3M
-45.12%262.4M
19.77%-311.7M
-37.36%236.7M
-54.15%143.2M
-Change in other current liabilities
5.00%23.1M
274.06%148.5M
2,059.26%105.8M
-37.43%83.9M
75.37%-63.2M
-86.87%22M
-81.00%39.7M
-109.73%-5.4M
276.69%134.1M
-1,003.52%-256.6M
Cash from discontinued investing activities
Operating cash flow
74.39%1.43B
837.19%3.63B
-14.81%498M
-9.37%1.24B
128.59%1.07B
-37.33%818.9M
-113.93%-492.6M
149.19%584.6M
7.99%1.37B
-430.89%-3.75B
Investing cash flow
Cash flow from continuing investing activities
-674.01%-431.9M
74.92%-945.4M
64.95%-288.1M
66.38%-117M
-4.49%-484.5M
97.39%-55.8M
-20.00%-3.77B
7.29%-821.9M
-195.67%-348M
-52.58%-463.7M
Net PPE purchase and sale
-227.76%-133.4M
-46.99%-437.6M
-61.34%-149.4M
-50.37%-101.8M
-111.16%-145.7M
40.50%-40.7M
-48.55%-297.7M
-59.38%-92.6M
-66.75%-67.7M
-15.77%-69M
Net intangibles purchase and sale
----
--0
--0
--0
--0
--0
-223.62%-187.7M
--0
--0
---7.7M
Net business purchase and sale
----
----
----
----
----
----
--0
--258M
----
----
Net investment purchase and sale
-2,945.92%-298.5M
85.05%-483.1M
87.16%-122.8M
-12.68%-16M
10.08%-334.5M
99.48%-9.8M
-13.26%-3.23B
-24.14%-956.4M
81.32%-14.2M
-73.51%-372M
Net other investing changes
----
54.26%-24.7M
48.54%-15.9M
109.88%800K
---4.3M
---5.3M
-74.19%-54M
---30.9M
-636.36%-8.1M
----
Cash from discontinued investing activities
Investing cash flow
-674.01%-431.9M
74.92%-945.4M
64.95%-288.1M
66.38%-117M
-4.49%-484.5M
97.39%-55.8M
-20.00%-3.77B
7.29%-821.9M
-195.67%-348M
-52.58%-463.7M
Financing cash flow
Cash flow from continuing financing activities
20.81%-538.8M
-51.27%-2.26B
80.27%-77.2M
-197.94%-1.15B
2.62%-349.2M
-90.32%-680.4M
-165.90%-1.49B
-226.63%-391.3M
-134.85%-387.5M
-2,172.83%-358.6M
Net issuance payments of debt
----
83.93%-5.4M
-7.69%-1.4M
74.07%-1.4M
90.51%-1.3M
90.15%-1.3M
25.17%-33.6M
89.17%-1.3M
52.21%-5.4M
-24.55%-13.7M
Net common stock issuance
18.83%-565.4M
-50.89%-2.39B
69.21%-130.9M
-196.91%-1.16B
0.77%-397.7M
-91.01%-696.6M
-142.02%-1.58B
-178.45%-425.2M
-129.96%-391.4M
-1,176.43%-400.8M
Proceeds from stock option exercised by employees
61.68%27M
11.43%127.7M
57.43%54M
-5.95%7.9M
-10.73%49.1M
-1.18%16.7M
-14.86%114.6M
-26.08%34.3M
-45.45%8.4M
-6.14%55M
Net other financing activities
20.00%-400K
-40.32%3.7M
22.22%1.1M
22.22%1.1M
122.22%2M
-114.29%-500K
244.44%6.2M
160.00%900K
-18.18%900K
-18.18%900K
Cash from discontinued financing activities
Financing cash flow
20.81%-538.8M
-51.27%-2.26B
80.27%-77.2M
-197.94%-1.15B
2.62%-349.2M
-90.32%-680.4M
-165.90%-1.49B
-226.63%-391.3M
-134.85%-387.5M
-2,172.83%-358.6M
Net cash flow
Beginning cash position
11.28%5.09B
-55.92%4.57B
-5.72%4.95B
8.52%4.98B
-48.90%4.69B
-55.92%4.57B
-1.33%10.37B
-52.79%5.25B
-54.78%4.59B
-1.36%9.17B
Current changes in cash
453.08%457.4M
107.38%424.7M
121.11%132.7M
-104.75%-30.1M
105.23%239.4M
106.97%82.7M
-3,355.88%-5.76B
18.54%-628.6M
-35.65%634.3M
-639.74%-4.58B
Effect of exchange rate changes
-232.13%-40.3M
313.38%90.9M
115.43%7.3M
-117.98%-4.1M
2,388.00%57.2M
295.51%30.5M
-258.36%-42.6M
-272.63%-47.3M
201.33%22.8M
-125.00%-2.5M
End cash Position
17.49%5.5B
11.28%5.09B
11.28%5.09B
-5.72%4.95B
8.52%4.98B
-48.90%4.69B
-55.92%4.57B
-55.92%4.57B
-52.79%5.25B
-54.78%4.59B
Free cash flow
66.37%1.29B
426.56%3.19B
-29.15%348.6M
-12.48%1.14B
124.21%927.4M
-26.46%778.2M
-129.83%-978M
315.19%492M
6.05%1.3B
-456.37%-3.83B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 74.39%1.43B837.19%3.63B-14.81%498M-9.37%1.24B128.59%1.07B-37.33%818.9M-113.93%-492.6M149.19%584.6M7.99%1.37B-430.89%-3.75B
Net income from continuing operations 59.59%1.03B838.09%3.95B30.46%1.19B3.59%1.08B128.74%1.03B-41.22%646.3M-114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B
Operating gains losses -------------75.93%2.6M-142.52%-5.4M-44.44%15M9,516.67%57.7M1,700.00%7.2M74.19%10.8M3,075.00%12.7M
Depreciation and amortization 15.50%55.9M1.25%209.8M19.78%55.7M1.50%54M-4.26%51.7M-9.53%48.4M14.29%207.2M-21.19%46.5M26.37%53.2M30.43%54M
Deferred tax 65.92%-65.3M-46.44%-510.8M-40.89%30.5M-91.32%-235.9M4.21%-113.8M-21.04%-191.6M34.99%-348.8M139.39%51.6M-6.75%-123.3M32.73%-118.8M
Other non cash items -112.76%-5M12,500.00%113.4M40.85%23.1M-116.11%-6.7M379.23%57.8M207.69%39.2M102.11%900K151.74%16.4M313.33%41.6M-84.82%-20.7M
Change In working capital 191.14%244.7M-132.93%-1.2B-69.19%-947.8M-5.02%149.6M45.15%-132.4M-307.66%-268.5M-93.75%-514.8M33.22%-560.2M-16.62%157.5M-198.37%-241.4M
-Change in receivables 123.47%39.8M-249.75%-347.3M-244.06%-99.4M-15.64%-59.9M-113.62%-18.4M32.59%-169.6M-18.07%-99.3M348.05%69M-749.18%-51.8M4,758.62%135.1M
-Change in inventory 41.53%-97.7M-1.33%-524.2M47.53%-77.4M28.16%-131.1M-38.62%-148.6M-108.61%-167.1M-60.20%-517.3M-110.71%-147.5M-87.18%-182.5M-47.25%-107.2M
-Change in prepaid assets 717.08%173.4M-97.70%-396M-52.25%-250.6M-294.76%-40.9M50.99%-76.4M-128.33%-28.1M63.29%-200.3M63.53%-164.6M117.36%21M-695.41%-155.9M
-Change in payables and accrued expense 42.80%106.1M-130.53%-80.1M-100.90%-626.2M25.73%297.6M21.65%174.2M-61.74%74.3M-45.12%262.4M19.77%-311.7M-37.36%236.7M-54.15%143.2M
-Change in other current liabilities 5.00%23.1M274.06%148.5M2,059.26%105.8M-37.43%83.9M75.37%-63.2M-86.87%22M-81.00%39.7M-109.73%-5.4M276.69%134.1M-1,003.52%-256.6M
Cash from discontinued investing activities
Operating cash flow 74.39%1.43B837.19%3.63B-14.81%498M-9.37%1.24B128.59%1.07B-37.33%818.9M-113.93%-492.6M149.19%584.6M7.99%1.37B-430.89%-3.75B
Investing cash flow
Cash flow from continuing investing activities -674.01%-431.9M74.92%-945.4M64.95%-288.1M66.38%-117M-4.49%-484.5M97.39%-55.8M-20.00%-3.77B7.29%-821.9M-195.67%-348M-52.58%-463.7M
Net PPE purchase and sale -227.76%-133.4M-46.99%-437.6M-61.34%-149.4M-50.37%-101.8M-111.16%-145.7M40.50%-40.7M-48.55%-297.7M-59.38%-92.6M-66.75%-67.7M-15.77%-69M
Net intangibles purchase and sale ------0--0--0--0--0-223.62%-187.7M--0--0---7.7M
Net business purchase and sale --------------------------0--258M--------
Net investment purchase and sale -2,945.92%-298.5M85.05%-483.1M87.16%-122.8M-12.68%-16M10.08%-334.5M99.48%-9.8M-13.26%-3.23B-24.14%-956.4M81.32%-14.2M-73.51%-372M
Net other investing changes ----54.26%-24.7M48.54%-15.9M109.88%800K---4.3M---5.3M-74.19%-54M---30.9M-636.36%-8.1M----
Cash from discontinued investing activities
Investing cash flow -674.01%-431.9M74.92%-945.4M64.95%-288.1M66.38%-117M-4.49%-484.5M97.39%-55.8M-20.00%-3.77B7.29%-821.9M-195.67%-348M-52.58%-463.7M
Financing cash flow
Cash flow from continuing financing activities 20.81%-538.8M-51.27%-2.26B80.27%-77.2M-197.94%-1.15B2.62%-349.2M-90.32%-680.4M-165.90%-1.49B-226.63%-391.3M-134.85%-387.5M-2,172.83%-358.6M
Net issuance payments of debt ----83.93%-5.4M-7.69%-1.4M74.07%-1.4M90.51%-1.3M90.15%-1.3M25.17%-33.6M89.17%-1.3M52.21%-5.4M-24.55%-13.7M
Net common stock issuance 18.83%-565.4M-50.89%-2.39B69.21%-130.9M-196.91%-1.16B0.77%-397.7M-91.01%-696.6M-142.02%-1.58B-178.45%-425.2M-129.96%-391.4M-1,176.43%-400.8M
Proceeds from stock option exercised by employees 61.68%27M11.43%127.7M57.43%54M-5.95%7.9M-10.73%49.1M-1.18%16.7M-14.86%114.6M-26.08%34.3M-45.45%8.4M-6.14%55M
Net other financing activities 20.00%-400K-40.32%3.7M22.22%1.1M22.22%1.1M122.22%2M-114.29%-500K244.44%6.2M160.00%900K-18.18%900K-18.18%900K
Cash from discontinued financing activities
Financing cash flow 20.81%-538.8M-51.27%-2.26B80.27%-77.2M-197.94%-1.15B2.62%-349.2M-90.32%-680.4M-165.90%-1.49B-226.63%-391.3M-134.85%-387.5M-2,172.83%-358.6M
Net cash flow
Beginning cash position 11.28%5.09B-55.92%4.57B-5.72%4.95B8.52%4.98B-48.90%4.69B-55.92%4.57B-1.33%10.37B-52.79%5.25B-54.78%4.59B-1.36%9.17B
Current changes in cash 453.08%457.4M107.38%424.7M121.11%132.7M-104.75%-30.1M105.23%239.4M106.97%82.7M-3,355.88%-5.76B18.54%-628.6M-35.65%634.3M-639.74%-4.58B
Effect of exchange rate changes -232.13%-40.3M313.38%90.9M115.43%7.3M-117.98%-4.1M2,388.00%57.2M295.51%30.5M-258.36%-42.6M-272.63%-47.3M201.33%22.8M-125.00%-2.5M
End cash Position 17.49%5.5B11.28%5.09B11.28%5.09B-5.72%4.95B8.52%4.98B-48.90%4.69B-55.92%4.57B-55.92%4.57B-52.79%5.25B-54.78%4.59B
Free cash flow 66.37%1.29B426.56%3.19B-29.15%348.6M-12.48%1.14B124.21%927.4M-26.46%778.2M-129.83%-978M315.19%492M6.05%1.3B-456.37%-3.83B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More